Alpha 2.0
Login Register
» Authors » Qiangling Yin

Qiangling Yin

Explore the profile of Qiangling Yin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 63
Followers 0
Related Specialties
Microbiology
Science
Top 10 Co-Authors
Mifang Liang
Lina Sun
Shiwen Wang
Jiandong Li
Dexin Li
Yuanyuan Qu
Wei Wu
Chuan Li
Kai Duan
Xiaoming Yang
Published In
Virol Sin
Sci Rep
China CDC Wkly
Cell Discov
Viruses
Affiliations
Soon will be listed here.
Recent Articles
1.
Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China
Liu Y, Zhang J, Liu W, Pan Y, Ruan S, Nian X, et al.
Emerg Microbes Infect . 2023 Nov; 13(1):2284297. PMID: 37970736
Following the national dynamic zero-COVID strategy adjustment, the utilization of broad-spectrum nasal neutralizing antibodies may offer an alternative approach to controlling the outbreak of Omicron variants between late 2022 and...
2.
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages
Li X, Pan Y, Yin Q, Wang Z, Shan S, Zhang L, et al.
Cell Discov . 2022 Sep; 8(1):87. PMID: 36075908
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs), especially the latest Omicron, have exhibited severe antibody evasion. Broadly neutralizing antibodies with high potency against Omicron are...
3.
Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants
Lu J, Yin Q, Pei R, Zhang Q, Qu Y, Pan Y, et al.
Virol Sin . 2022 May; 37(2):238-247. PMID: 35527227
Multiple new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have constantly emerged, as the delta and omicron variants, which have developed resistance to currently gained neutralizing antibodies. This...
4.
Hemorrhagic Fever with Renal Syndrome - Liaoning Province, China, 1999-2018
Shang C, Sun Y, Yin Q, Huang X, Liu X, Zhang Q, et al.
China CDC Wkly . 2021 Oct; 2(20):350-354. PMID: 34594659
Hemorrhagic fever with renal syndrome (HFRS) is endemic in Liaoning Province. Both Seoul and Hantaan virus are circulating in rodents, and epidemic outbreaks and sporadic cases have been recorded every...
5.
Chemiluminescence Immunoassay Based Serological Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Vaccinated Population
Yin Q, Zhang Y, Lian L, Qu Y, Wu W, Chen Z, et al.
Viruses . 2021 Aug; 13(8). PMID: 34452373
The development of rapid serological detection methods re urgently needed for determination of neutralizing antibodies in sera. In this study, four rapid methods (ACE2-RBD inhibition assay, S1-IgG detection, RBD-IgG detection,...
6.
Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants
Qu Y, Zhang X, Wang M, Sun L, Jiang Y, Li C, et al.
Virol Sin . 2021 Jul; 36(5):934-947. PMID: 34224110
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has precipitated multiple variants resistant to therapeutic antibodies. In this study, 12 high-affinity antibodies were generated from convalescent donors in early outbreaks using...
7.
Abnormal upregulation of cardiovascular disease biomarker PLA2G7 induced by proinflammatory macrophages in COVID-19 patients
Li Y, Jiang Y, Zhang Y, Li N, Yin Q, Liu L, et al.
Sci Rep . 2021 Mar; 11(1):6811. PMID: 33762651
High rate of cardiovascular disease (CVD) has been reported among patients with coronavirus disease 2019 (COVID-19). Importantly, CVD, as one of the comorbidities, could also increase the risks of the...